News from us and our partners

Tags

Topics

0 results

News
14 March, 2020
FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market
News
5 March, 2020
Biotalys announces second closing of €45 million Series C financing round
News
19 February, 2020
Bommy Lee Joins Sofinnova Partners as Head of Communications
News
23 January, 2020
Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers
News
15 January, 2020
Sofinnova Partners Announces the Promotion of Michael Krel to Partner of Industrial Biotechnology Team
News
7 January, 2020
HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry
News
16 December, 2019
MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis
News
22 November, 2019
Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock
News
21 November, 2019
TISSIUM Closes €39M Series B Funding Round
News
8 November, 2019
Avantium nominates Edwin Moses as Chairman of its Supervisory Board
News
17 October, 2019
Sofinnova Partners raises €333 million capital IX early-stage healthcare fund
News
16 October, 2019
ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
News
10 October, 2019
iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board Apollon Papadimitriou, Ph.D., Named Chief Executive Officer; Marcus Irsfeld Appointed as Chief Financial Officer
News
7 October, 2019
Micropep Technologies Strengthens Its Management Team by Appointing Dr. Mikael Courbot as Chief Technical Officer
News
12 September, 2019
Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics
News
23 August, 2019
HotSpot Therapeutics acquires Macroceutics to expand DEL platform

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Biotalys announces second closing of €45 million Series C financing round

Bommy Lee Joins Sofinnova Partners as Head of Communications

Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers

Sofinnova Partners Announces the Promotion of Michael Krel to Partner of Industrial Biotechnology Team

HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis

Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock

TISSIUM Closes €39M Series B Funding Round

Avantium nominates Edwin Moses as Chairman of its Supervisory Board

Sofinnova Partners raises €333 million capital IX early-stage healthcare fund

ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board Apollon Papadimitriou, Ph.D., Named Chief Executive Officer; Marcus Irsfeld Appointed as Chief Financial Officer

Micropep Technologies Strengthens Its Management Team by Appointing Dr. Mikael Courbot as Chief Technical Officer

Inotrem announces €39 Million Series B Financing to Develop First- In-Class Immunology Therapeutics

HotSpot Therapeutics acquires Macroceutics to expand DEL platform